LEADER 01017nam0 2200265 450 001 9910595999803321 005 20221019104224.0 100 $a20221019d1958----kmuy0itay5050 ba 101 0 $alat 102 $aES 105 $a 001yy 200 1 $a<<2: >>Tractatus de virtutibus theologicis. De statibus particularibus. De sacramentis. De delictis et poenis$fauctore P. Marcellino Zalba 210 $aMatriti$cLa Editorial Católica$d1958 215 $aXV, 1018 p.$d20 cm 225 1 $aBiblioteca de autores cristianos$v176 461 1$1200$aTheologiae moralis compendium$eiuxta constitutionem Apostolicam Deus Scientiarum Dominus$fMacellinus Zalba$vVol. 2 676 $a241$v21$zita 700 1$aZalba,$bMarcellino$01260538 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910595999803321 952 $aIII N 24$b90784$fFGBC 959 $aFGBC 996 $aTractatus de virtutibus theologicis. De statibus particularibus. De sacramentis. De delictis et poenis$92921327 997 $aUNINA LEADER 05298nam 22008175 450 001 9910595053503321 005 20251009103347.0 010 $a3-031-08309-1 024 7 $a10.1007/978-3-031-08309-9 035 $a(MiAaPQ)EBC7098170 035 $a(Au-PeEL)EBL7098170 035 $a(CKB)24866047200041 035 $a(PPN)264960491 035 $a(DNLM)9918697772706676 035 $a(DE-He213)978-3-031-08309-9 035 $a(OCoLC)1345580469 035 $a(EXLCZ)9924866047200041 100 $a20220920d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCardiovascular Signaling in Health and Disease /$fedited by Narasimham L. Parinandi, Thomas J. Hund 205 $a1st ed. 2022. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022. 215 $a1 online resource (535 pages) 225 1 $aBiomedical and Life Sciences Series 311 08$aPrint version: Parinandi, Narasimham L. Cardiovascular Signaling in Health and Disease Cham : Springer International Publishing AG,c2022 9783031083082 327 $aPart 1: Cardiac Signaling -- Chapter 1: Calcium-Dependent Signaling in Cardiac Myocytes -- Chapter 2: Organization of Ca2+ Signaling Microdomains in Cardiac Myocytes -- Chapter 3: Stress Kinase Signaling in Cardiac Myocytes -- Chapter 4: Cardiotoxicity and cardiac cell signaling -- Chapter 5: Protein Phosphatase Signaling in Cardiac Myocytes -- Chapter 6: Metabolic Regulation of Mitochondrial Dynamics and Cardiac Function -- Chapter 7: NADPH Oxidase System Mediates Cholesterol Secoaldehyde-Induced Oxidative Stress and Cytotoxicity in H9c2 Cardiomyocytes -- Chapter 8: Lipid Mediators in Cardiovascular Physiology and Disease -- Chapter 9: Cardiac Inflammasome and Arrhythmia -- Chapter 10: Myocardial Fibrosis: Cell Signaling and In Vitro Modeling -- Chapter 11: Neural regulation of cardiac rhythm -- Part 2: Vascular Signaling -- Chapter 12: Mechanisms of lipoproteins and reverse cholesterol transport in atherosclerotic cardiovascular disease -- Chapter 13: Atherosclerotic plaque regression: Future perspective -- Chapter 14: Role of Bioactive Lipid, Phosphatidic Acid in Hypercholesterolemia Drug-induced Myotoxicity ? Statin-induced Phospholipase D (PLD) Lipid Signaling in Skeletal Muscle Cells -- Chapter 15: Cell-Cell Communication in the Vascular Endothelium -- Chapter 16: Lysophosphatidic acid regulates endothelial barrier integrity -- Chapter 17: Regulation of Vascular Endothelial Barrier Integrity and Function by Lipid-Derived Mediators -- Chapter 18: Hyperglycemic Oxoaldehyde (Glyoxal)-induced Vascular Endothelial Cell Damage through Oxidative Stress is protected by Thiol Iron Chelator, Dimercaptosuccinic Acid ? Role of Iron in Diabetic Vascular Endothelial Dysfunction. 330 $aThis contributed volume focuses on cardiovascular diseases (CVDs), and explores the ways in which signaling mechanisms at the biochemical, molecular, and cellular levels in the blood vessels (vascular) and heart contribute to the underlying causes of development and progression of the CVDs. This volume covers unique topics such as oxidant signaling in vascular and heart diseases and health, cytoskeletal signaling in vascular health and disease, phospholipase signaling in CVDs, lipid signaling in vascular and myocardial health and diseases, and drug discovery in cellular signaling for cardiovascular diseases. This book assembles the most important discoveries made by leaders on the cellular signaling mechanisms operating behind the development and progression of life-threatening CVDs. It is an extremely useful resource for the investigators in the field of CVDs, and opens the discussion for further discovery of efficient management and effective treatmentof the CVDs. 410 0$aBiomedical and Life Sciences Series 606 $aBiophysics 606 $aCell interaction 606 $aBiomedical engineering 606 $aCardiovascular system 606 $aPhysiology 606 $aCardiography 606 $aMolecular biology 606 $aClinical biochemistry 606 $aMechanobiological Cell Signaling 606 $aBiomedical Engineering and Bioengineering 606 $aCardiovascular Physiology 606 $aCardiography 606 $aMolecular Biology 606 $aMedical Biochemistry 615 0$aBiophysics. 615 0$aCell interaction. 615 0$aBiomedical engineering. 615 0$aCardiovascular system. 615 0$aPhysiology. 615 0$aCardiography. 615 0$aMolecular biology. 615 0$aClinical biochemistry. 615 14$aMechanobiological Cell Signaling. 615 24$aBiomedical Engineering and Bioengineering. 615 24$aCardiovascular Physiology. 615 24$aCardiography. 615 24$aMolecular Biology. 615 24$aMedical Biochemistry. 676 $a616.1 676 $a616.1071 700 $aParinandi$b Narasimham L.$01258090 702 $aHund$b Thomas J. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910595053503321 996 $aCardiovascular Signaling in Health and Disease$92915795 997 $aUNINA